"10.1371_journal.pone.0070917","plos one","2013-08-05T00:00:00Z","Lesley M E McCowan; John M D Thompson; Rennae S Taylor; Robyn A North; Lucilla Poston; Philip N Baker; Jenny Myers; Claire T Roberts; Gustaaf A Dekker; Nigel A B Simpson; James J Walker; Louise C Kenny; on behalf of the SCOPE Consortium","Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand; National Womens, Auckland District Health Board, Auckland, New Zealand; Department of Paediatrics, University of Auckland, Auckland, New Zealand; Division of Womens Health, Womens Health Academic Centre, Kings College London and Kings Health Partners, London, United Kingdom; Liggins Institute, University of Auckland, Auckland, New Zealand; Maternal and Fetal Heath Research Centre, University of Manchester, Manchester, United Kingdom; Robinson Institute, University of Adelaide, Adelaide, Australia; Women and Childrens Division, Lyell McEwin Hospital, University of Adelaide, Adelaide, Australia; Section of Obstetrics and Gynaecology, Institute of Biochemical and Clinical Sciences, University of Leeds, Leeds, United Kingdom; INFANT (The Irish Centre for Fetal and Neonatal Translational Research) Department of Obstetrics and Gynaecology, University College, Cork, Ireland","Conceived and designed the experiments: LM RAN GAD LP JJW JMDT. Analyzed the data: JMDT LM RST. Wrote the paper: LM JMDT RST RAN LP PNB JM CTR GAD NABS JJW LK.","The following do not have any conflicts of interest: LM, JMDT, RST, LP, JM, CR, GAD and NABS. The following declare potential competing interests: RN declares the following: a patent which to date has not been licensed to a company: Blumenstein M, North RA, McMaster MT, Black MA, Kasabov NK, Cooper GJS. Biomarkers for prediction of pre-eclampsia and/or cardiovascular disease. PCT number WO/2009/108073. RN has a research grant from Alere, USA, to Kings College London to investigate biomarkers for preeclampsia. RN had a consultancy with Pronota, Belgium, on biomarkers for preeclampsia through a grant from Pronota to Kings College London. PB and LK have minority share holdings in Metabolomic Diagnostics, a company with an interest in preeclampsia and SGA biomarkers, based on technology developed by PB and LK and licensed from University College Cork. JJW declares that he is the Senior Vice-President of the RCOG with a remit for Global Health. He is the Medical Director of APEC, a patient Charity for Pre-eclampsia in the UK. He is a medical adviser for Alere, a Biomarker Company and has been paid both to advise and speak on their behalf. None of the authors have support from any company for the submitted work. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Lesley M E McCowan","LMEMC",13,TRUE,6,NA,3,12,TRUE,TRUE,TRUE,1,"13",TRUE
